Josh SNYDER
10Patents
3h-index
17Co-inventors
49Inventor score
Filing activity: Aug 23, 2013 → May 4, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9925273B2 | Antibody drug conjugates (ADC) that bind to CD37 proteins | Human Necessities | 6 | Active |
| USRE47103E1 | Antibody drug conjugates (ADC) that bind to 158P1D7 proteins | General | 6 | Active |
| US8968742B2 | Antibody drug conjugates (ADC) that bind to 158P1D7 proteins | Chemistry; Metallurgy | 5 | Active |
| US9926376B2 | Antibody drug conjugates (ADC) that bind to 158P1D7 proteins | Chemistry; Metallurgy | 3 | Active |
| US10646583B2 | Antibody drug conjugates (ADC) that bind to CD37 proteins | Human Necessities | 2 | Active |
| US10669348B2 | Antibody drug conjugates (ADC) that bind to 158P1D7 proteins | Chemistry; Metallurgy | 2 | Active |
| US9974865B2 | Antibody drug conjugates (ADC) that bind to FLT3 proteins | Chemistry; Metallurgy | 1 | Active |
| US10751422B2 | Antibody drug conjugates (ADC) that bind to FLT3 proteins | Chemistry; Metallurgy | 1 | Active |
| US11633500B2 | Antibody drug conjugates (ADC) that bind to CD37 proteins | Human Necessities | 0 | Active |
| US11634503B2 | Antibody drug conjugates (ADC) that bind to 158P1D7 proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.